Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder
← Find more feeds

sanofi.com

Sanofi

Get the latest updates from Sanofi directly as they happen.

Follow now 112 followers

Latest posts

Last updated about 1 year ago

Soliqua® Phase 3 results significantly lowered blood sugar levels compared to GLP-1 receptor agonist treatments

almost 5 years ago

Paul Hudson to succeed Olivier Brandicourt as Chief Executive Officer

almost 5 years ago

Phase 3 trial of isatuximab combination therapy showed 40% reduction in the risk of disease progression or death for patients with relapsed/refractory multiple myeloma

almost 5 years ago

Sanofi : Dupixent® (dupilumab) Approved for Severe Asthma by European Commission

almost 5 years ago

Sanofi: Annual General Meeting of April 30, 2019

almost 5 years ago

Sanofi: FDA approves Praluent® (alirocumab) to prevent heart attack, stroke and unstable angina requiring hospitalization

almost 5 years ago

ZynquistaTM now approved in the European Union for treatment of adults with type 1 diabetes

almost 5 years ago

CHMP issues positive opinion for Libtayo® (cemiplimab) in advanced cutaneous squamous cell carcinoma

almost 5 years ago

Sanofi delivers strong Q1 2019 business EPS growth of 9.4% at CER

almost 5 years ago

Sanofi: Sanofi and Alnylam conclude research and option phase of 2014 rare disease alliance

about 5 years ago

Sanofi: Availability of the Pre-quarterly Results Communication

about 5 years ago

Sanofi: FDA issues Complete Response Letter for Zynquista(TM) (sotagliflozin)

about 5 years ago

Sign up to continue

Try Feeder for free

Everything you care about in one place

Try Feeder now